肿瘤基础与临床
腫瘤基礎與臨床
종류기출여림상
JOURNAL OF BASIC AND CLINICAL ONCOLOGY
2014年
6期
482-484
,共3页
三阴性乳腺癌%Ki-67%多西他赛%顺铂%化疗
三陰性乳腺癌%Ki-67%多西他賽%順鉑%化療
삼음성유선암%Ki-67%다서타새%순박%화료
triple-negative breast cancer%Ki-67%docetaxel%cisplatin%chemotherapy
目的:探讨三阴性乳腺癌( TNBC)组织Ki-67表达与多西他赛联合顺铂化疗疗效之间的关系。方法选取术后胸壁局部复发和(或)区域淋巴结转移的女性TNBC患者50例,复发或转移病灶行穿刺活检术,应用免疫组化方法检测Ki-67的表达,分为区域淋巴结转移组、无区域淋巴结转移组,Ki-67阳性表达组及阴性表达组。应用多西他赛联合顺铂方案化疗,3周期后进行疗效评价。结果区域淋巴结转移组及无区域淋巴结转移组Ki-67阳性表达差异有统计学意义(χ2=4.402,P=0.036)。3周期化疗后Ki-67阳性表达组有效率85.71%(30/35),Ki-67阴性表达组有效率60.00%(9/15),差异有统计学意义(χ2=4.406,P=0.044)。结论多西他赛联合顺铂治疗术后出现胸壁局部复发和(或)区域淋巴结转移的TNBC疗效较好, Ki-67阳性表达的TNBC患者对该方案化疗更敏感。
目的:探討三陰性乳腺癌( TNBC)組織Ki-67錶達與多西他賽聯閤順鉑化療療效之間的關繫。方法選取術後胸壁跼部複髮和(或)區域淋巴結轉移的女性TNBC患者50例,複髮或轉移病竈行穿刺活檢術,應用免疫組化方法檢測Ki-67的錶達,分為區域淋巴結轉移組、無區域淋巴結轉移組,Ki-67暘性錶達組及陰性錶達組。應用多西他賽聯閤順鉑方案化療,3週期後進行療效評價。結果區域淋巴結轉移組及無區域淋巴結轉移組Ki-67暘性錶達差異有統計學意義(χ2=4.402,P=0.036)。3週期化療後Ki-67暘性錶達組有效率85.71%(30/35),Ki-67陰性錶達組有效率60.00%(9/15),差異有統計學意義(χ2=4.406,P=0.044)。結論多西他賽聯閤順鉑治療術後齣現胸壁跼部複髮和(或)區域淋巴結轉移的TNBC療效較好, Ki-67暘性錶達的TNBC患者對該方案化療更敏感。
목적:탐토삼음성유선암( TNBC)조직Ki-67표체여다서타새연합순박화료료효지간적관계。방법선취술후흉벽국부복발화(혹)구역림파결전이적녀성TNBC환자50례,복발혹전이병조행천자활검술,응용면역조화방법검측Ki-67적표체,분위구역림파결전이조、무구역림파결전이조,Ki-67양성표체조급음성표체조。응용다서타새연합순박방안화료,3주기후진행료효평개。결과구역림파결전이조급무구역림파결전이조Ki-67양성표체차이유통계학의의(χ2=4.402,P=0.036)。3주기화료후Ki-67양성표체조유효솔85.71%(30/35),Ki-67음성표체조유효솔60.00%(9/15),차이유통계학의의(χ2=4.406,P=0.044)。결론다서타새연합순박치료술후출현흉벽국부복발화(혹)구역림파결전이적TNBC료효교호, Ki-67양성표체적TNBC환자대해방안화료경민감。
Objective To investigate the relationship between Ki-67 expression and efficacy of docetaxel com-bined with cisplatin for triple-negative breast cancer( TNBC). Methods Fifty female postoperative patients with TNBC accompanied with chest wall recurrence and( or)regional lymph node metastasis,recurrent or metastatic le-sions for biopsy,and immunohistochemistry was used to detect the Ki-67 expression. All the patients were divided into the regional lymph node metastasis group and the no regional lymph node metastasis group,the positive expre-ssion of Ki-67 group and the negative expression of Ki-67 group. Docetaxel combined with cisplatin was used to treat all the patients,one cycle was 21 days,the efficacy were evaluated after 3 cycles of chemotherapy. Results There were statistical differences in the Ki-67 expression between the regional lymph node metastasis group and the no regional lymph node metastasis group(χ2 =4. 402,P =0. 036 ). After 3 cycles of chemotherapy,the response rate was 85. 71%(30/35)of the positive expression of Ki-67 group,and was 60. 00%(9/15)of the negative expression of Ki-67 group(χ2 =4. 406,P=0. 044). Conclusion Docetaxel combined with cisplatin is highly effect in the treat-ment of chest wall recurrence and( or)regional lymph node metastasis in postoperative patients with TNBC,among the patients with TNBC in the positive expression of Ki-67 group had the better efficiency.